AAPL333.68+12.02 (+3.74%) ▲|ABBV258.99+2.07 (+0.81%) ▲|ABT103.41+2.66 (+2.64%) ▲|ACN145.26+6.52 (+4.70%) ▲|ADBE222.64+10.47 (+4.93%) ▲|AMAT554.56-8.24 (-1.46%) ▼|AMD540.66+0.97 (+0.18%) ▲|AMGN376.31+4.81 (+1.29%) ▲|AMT167.64+2.99 (+1.81%) ▲|AMZN233.76+0.10 (+0.04%) ▲|AVGO386.30-6.17 (-1.57%) ▼|AXP323.50-17.34 (-5.09%) ▼|BA212.20+2.97 (+1.42%) ▲|BAC62.11+0.83 (+1.36%) ▲|BKNG178.30+5.47 (+3.17%) ▲|BLK1,051.03+13.87 (+1.34%) ▲|BMY62.31+0.80 (+1.29%) ▲|BNY159.71-0.41 (-0.25%) ▼|BRK-B495.31+4.46 (+0.91%) ▲|C132.64+0.76 (+0.57%) ▲|CAT900.65+6.11 (+0.68%) ▲|CL90.44+0.36 (+0.40%) ▲|CMCSA22.22+0.30 (+1.35%) ▲|COF203.00+3.04 (+1.52%) ▲|COP120.00-0.20 (-0.17%) ▼|COST931.57+5.51 (+0.59%) ▲|CRM162.54+5.61 (+3.57%) ▲|CSCO114.10+1.34 (+1.19%) ▲|CVS107.61+0.72 (+0.67%) ▲|CVX194.59+0.17 (+0.08%) ▲|DE621.33+11.31 (+1.85%) ▲|DHR191.66-0.84 (-0.44%) ▼|DIS95.60+2.77 (+2.98%) ▲|DUK129.78+0.52 (+0.40%) ▲|EMR149.15+4.25 (+2.93%) ▲|FDX317.24+1.62 (+0.51%) ▲|GD386.10+4.31 (+1.13%) ▲|GE357.12+8.12 (+2.33%) ▲|GEV1,025.39-5.80 (-0.56%) ▼|GILD130.26-0.60 (-0.46%) ▼|GM83.30+2.63 (+3.26%) ▲|GOOG319.53+1.19 (+0.37%) ▲|GOOGL319.73+2.04 (+0.64%) ▲|GS1,072.63-2.09 (-0.19%) ▼|HD330.54+5.83 (+1.80%) ▲|HON241.42-4.86 (-1.97%) ▼|IBM215.22+8.57 (+4.15%) ▲|INTC95.66-4.57 (-4.56%) ▼|INTU292.53+11.00 (+3.91%) ▲|ISRG339.93+7.91 (+2.38%) ▲|JNJ262.95+3.68 (+1.42%) ▲|JPM353.04+3.14 (+0.90%) ▲|KO81.85+0.68 (+0.83%) ▲|LIN508.74+2.42 (+0.48%) ▲|LLY1,200.92+15.05 (+1.27%) ▲|LMT580.05+11.46 (+2.02%) ▲|LOW206.26+4.34 (+2.15%) ▲|LRCX316.59-3.20 (-1.00%) ▼|MA535.04+4.75 (+0.90%) ▲|MCD265.54+2.74 (+1.04%) ▲|MDLZ60.12+0.07 (+0.12%) ▲|MDT83.06+1.05 (+1.28%) ▲|META603.60-2.50 (-0.41%) ▼|MMM172.05+2.46 (+1.45%) ▲|MO72.84+0.76 (+1.05%) ▲|MRK131.25+0.77 (+0.59%) ▲|MS215.61+0.43 (+0.20%) ▲|MSFT384.83+3.25 (+0.85%) ▲|MU944.25-45.97 (-4.64%) ▼|NEE89.57-0.22 (-0.25%) ▼|NFLX69.96+1.07 (+1.55%) ▲|NKE41.78+0.79 (+1.93%) ▲|NOW97.50+5.56 (+6.05%) ▲|NVDA210.84+2.08 (+1.00%) ▲|ORCL118.37-1.67 (-1.39%) ▼|PEP135.88+0.93 (+0.69%) ▲|PFE24.63+0.05 (+0.18%) ▲|PG147.04+1.15 (+0.79%) ▲|PLTR123.66+0.29 (+0.24%) ▲|PM193.35+2.23 (+1.17%) ▲|QCOM169.70-1.41 (-0.82%) ▼|RTX213.70+4.54 (+2.17%) ▲|SBUX104.37+1.16 (+1.12%) ▲|SCHW101.92+0.31 (+0.30%) ▲|SO96.87+0.27 (+0.28%) ▲|SPG228.93+3.73 (+1.66%) ▲|T23.75+0.79 (+3.42%) ▲|TMO560.20-12.12 (-2.12%) ▼|TMUS178.67+8.25 (+4.84%) ▲|TSLA310.90-8.80 (-2.75%) ▼|TXN280.23-4.76 (-1.67%) ▼|UBER69.55+0.64 (+0.93%) ▲|UNH421.57-1.99 (-0.47%) ▼|UNP308.30+3.97 (+1.30%) ▲|UPS114.80+0.70 (+0.61%) ▲|USB64.00+0.67 (+1.05%) ▲|V354.26+2.66 (+0.76%) ▲|VZ45.19+1.37 (+3.12%) ▲|WFC86.76+0.57 (+0.66%) ▲|WMT109.11+0.71 (+0.66%) ▲|XOM156.61-0.28 (-0.18%) ▼|AAPL333.68+12.02 (+3.74%) ▲|ABBV258.99+2.07 (+0.81%) ▲|ABT103.41+2.66 (+2.64%) ▲|ACN145.26+6.52 (+4.70%) ▲|ADBE222.64+10.47 (+4.93%) ▲|AMAT554.56-8.24 (-1.46%) ▼|AMD540.66+0.97 (+0.18%) ▲|AMGN376.31+4.81 (+1.29%) ▲|AMT167.64+2.99 (+1.81%) ▲|AMZN233.76+0.10 (+0.04%) ▲|AVGO386.30-6.17 (-1.57%) ▼|AXP323.50-17.34 (-5.09%) ▼|BA212.20+2.97 (+1.42%) ▲|BAC62.11+0.83 (+1.36%) ▲|BKNG178.30+5.47 (+3.17%) ▲|BLK1,051.03+13.87 (+1.34%) ▲|BMY62.31+0.80 (+1.29%) ▲|BNY159.71-0.41 (-0.25%) ▼|BRK-B495.31+4.46 (+0.91%) ▲|C132.64+0.76 (+0.57%) ▲|CAT900.65+6.11 (+0.68%) ▲|CL90.44+0.36 (+0.40%) ▲|CMCSA22.22+0.30 (+1.35%) ▲|COF203.00+3.04 (+1.52%) ▲|COP120.00-0.20 (-0.17%) ▼|COST931.57+5.51 (+0.59%) ▲|CRM162.54+5.61 (+3.57%) ▲|CSCO114.10+1.34 (+1.19%) ▲|CVS107.61+0.72 (+0.67%) ▲|CVX194.59+0.17 (+0.08%) ▲|DE621.33+11.31 (+1.85%) ▲|DHR191.66-0.84 (-0.44%) ▼|DIS95.60+2.77 (+2.98%) ▲|DUK129.78+0.52 (+0.40%) ▲|EMR149.15+4.25 (+2.93%) ▲|FDX317.24+1.62 (+0.51%) ▲|GD386.10+4.31 (+1.13%) ▲|GE357.12+8.12 (+2.33%) ▲|GEV1,025.39-5.80 (-0.56%) ▼|GILD130.26-0.60 (-0.46%) ▼|GM83.30+2.63 (+3.26%) ▲|GOOG319.53+1.19 (+0.37%) ▲|GOOGL319.73+2.04 (+0.64%) ▲|GS1,072.63-2.09 (-0.19%) ▼|HD330.54+5.83 (+1.80%) ▲|HON241.42-4.86 (-1.97%) ▼|IBM215.22+8.57 (+4.15%) ▲|INTC95.66-4.57 (-4.56%) ▼|INTU292.53+11.00 (+3.91%) ▲|ISRG339.93+7.91 (+2.38%) ▲|JNJ262.95+3.68 (+1.42%) ▲|JPM353.04+3.14 (+0.90%) ▲|KO81.85+0.68 (+0.83%) ▲|LIN508.74+2.42 (+0.48%) ▲|LLY1,200.92+15.05 (+1.27%) ▲|LMT580.05+11.46 (+2.02%) ▲|LOW206.26+4.34 (+2.15%) ▲|LRCX316.59-3.20 (-1.00%) ▼|MA535.04+4.75 (+0.90%) ▲|MCD265.54+2.74 (+1.04%) ▲|MDLZ60.12+0.07 (+0.12%) ▲|MDT83.06+1.05 (+1.28%) ▲|META603.60-2.50 (-0.41%) ▼|MMM172.05+2.46 (+1.45%) ▲|MO72.84+0.76 (+1.05%) ▲|MRK131.25+0.77 (+0.59%) ▲|MS215.61+0.43 (+0.20%) ▲|MSFT384.83+3.25 (+0.85%) ▲|MU944.25-45.97 (-4.64%) ▼|NEE89.57-0.22 (-0.25%) ▼|NFLX69.96+1.07 (+1.55%) ▲|NKE41.78+0.79 (+1.93%) ▲|NOW97.50+5.56 (+6.05%) ▲|NVDA210.84+2.08 (+1.00%) ▲|ORCL118.37-1.67 (-1.39%) ▼|PEP135.88+0.93 (+0.69%) ▲|PFE24.63+0.05 (+0.18%) ▲|PG147.04+1.15 (+0.79%) ▲|PLTR123.66+0.29 (+0.24%) ▲|PM193.35+2.23 (+1.17%) ▲|QCOM169.70-1.41 (-0.82%) ▼|RTX213.70+4.54 (+2.17%) ▲|SBUX104.37+1.16 (+1.12%) ▲|SCHW101.92+0.31 (+0.30%) ▲|SO96.87+0.27 (+0.28%) ▲|SPG228.93+3.73 (+1.66%) ▲|T23.75+0.79 (+3.42%) ▲|TMO560.20-12.12 (-2.12%) ▼|TMUS178.67+8.25 (+4.84%) ▲|TSLA310.90-8.80 (-2.75%) ▼|TXN280.23-4.76 (-1.67%) ▼|UBER69.55+0.64 (+0.93%) ▲|UNH421.57-1.99 (-0.47%) ▼|UNP308.30+3.97 (+1.30%) ▲|UPS114.80+0.70 (+0.61%) ▲|USB64.00+0.67 (+1.05%) ▲|V354.26+2.66 (+0.76%) ▲|VZ45.19+1.37 (+3.12%) ▲|WFC86.76+0.57 (+0.66%) ▲|WMT109.11+0.71 (+0.66%) ▲|XOM156.61-0.28 (-0.18%) ▼|
25.9 C
New York
Friday, July 24, 2026

Tag: treatment planning

newssourceFORcompanyinformationcontent1releasesmarket

Castle Biosciences Announces New York State Department of Health Approval of its AdvanceAD-Tx™ Test

Approval expands access to Castle's precision medicine test designed to guide systemic treatment decision making in patients with moderate-to-severe atopic dermatitisFRIENDSWOOD, Texas, July 14,...

DecisionDx®-Melanoma’s i31-SLNB Outperforms MIA Nomogram in Identifying Patients Who May Safely Forgo Sentinel Lymph Node Biopsy

Newly published prospective study shows DecisionDx-Melanoma's i31-SLNB test result more accurately identifies patients at low and high risk of sentinel lymph node (SLN) positivity...

Calgon Carbon Launches Filtrasorb Rx

Calgon Carbon launches product backed by a third-party validated, peer-reviewed study with measured PFAS Destruction Removal efficiency greater than 99.9%.

Dentistry Expert Dr. Allen Blourchian Explains Best Dental Implant Options in HelloNation

FRANKLIN, Tenn., June 19, 2026 /PRNewswire/ -- What are the best dental implant options for restoring both function and aesthetics after tooth loss? In HelloNation,...

Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

FRIENDSWOOD, Texas, June 19, 2026 /PRNewswire/ -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today...

Desert Hope Treatment Center Launches First Responder Lifeline Program, Offering Confidential Care for Frontline Heroes

Desert Hope Treatment Center has launched its First Responder Lifeline Program for law enforcement officers, firefighters, and public safety professionals.

KFSH Showcases Trusted AI as the Foundation for Scalable Healthcare Transformation at HLTH Europe 2026

RIYADH, Saudi Arabia, June 13, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSH) will use its participation at HLTH Europe 2026, taking place from June 15 to 18 in Amsterdam, to advance a clear message: artificial intelligence in healthcare will only scale when institutions can prove that it is safe, reliable, governed, and trusted by clinicians and patients.

PreludeDx™ Achieves New Milestones for DCIS Patients and DCISionRT® Testing

LAGUNA HILLS, Calif., June 12, 2026 /PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in precision diagnostics for breast cancer, today highlighted a new milestone...

KFSH Highlights the Strategic Value of Tertiary Care AI Datasets in Advancing Precision Medicine and Clinical Innovation

RIYADH, Saudi Arabia, June 12, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSH) will use its participation at HLTH Europe 2026, taking place from June 15 to 18 in Amsterdam, to highlight the strategic value of tertiary care datasets as a foundation for advancing artificial intelligence, precision medicine, and clinical innovation in highly specialized healthcare.

Global Rise in Delayed Childbearing and Infertility Drives Demand for Cross-Border Fertility Care

Asian Case Studies Highlight How Regulation, Cost, and Access Are Shaping International Family ChoicesTAIPEI, June 6, 2026 /PRNewswire/ -- Delayed marriage, postponed childbearing, and...

Fighting the Global Fertility Crisis! Taiwan Pioneers AI-Powered Embryo Selection Model — Improving Chromosomally Normal Embryo Identification Rate by Up to 24%

Breaking Through the "Blind Selection" Dilemma in Clinical Practice — TFC Taipei Fertility Center Introduces AI Scoring System to Help Infertile Couples End the...

New Research Revealed Effective Surgical Management Techniques for Gynecomastia in Asian Men, Resulting in High Patient Satisfaction

Between 2018 and 2023, Dr Ivan Puah treated over 550 cases, addressing unique challenges in Singapore's multi-ethnic population. His study included diverse case profiles....

Booking Health Unveils New Study: Role of Immunotherapy in Extending Life Expectancy for Stage4 Cervical Cancer Patients

Langenfeld, Germany, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Booking Health, a global leader in medical treatment coordination, today unveiled a new study titled Role of Immunotherapy in Extending Life Expectancy for Stage 4 Cervical Cancer Patients. The report outlines how cutting-edge immunotherapy is reshaping care for women with advanced cervical cancer, offering new pathways to longer survival and improved quality of life, particularly in cases resistant to standard treatments.

Pheton Holdings Ltd Issues Statements Addressing Recent Market Activity and Misleading Rumors

BEIJING, China, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (the “Company,” “we,” “our” or “Pheton”), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products and services, today issued the following statements in response to recent market volatility and a third-party publication that has raised questions and concerns among shareholders.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsTreatment planning

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers